These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 25086915)

  • 1. Synthesis and anticancer activities of novel 1,2,4-triazolo[3,4-a]phthalazine derivatives.
    Xue DQ; Zhang XY; Wang CJ; Ma LY; Zhu N; He P; Shao KP; Chen PJ; Gu YF; Zhang XS; Wang CF; Ji CH; Zhang QR; Liu HM
    Eur J Med Chem; 2014 Oct; 85():235-44. PubMed ID: 25086915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
    Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
    Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
    Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
    Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and antiproliferative activity studies of novel 1,2,3-triazole-dithiocarbamate-urea hybrids.
    Duan YC; Zheng YC; Li XC; Wang MM; Ye XW; Guan YY; Liu GZ; Zheng JX; Liu HM
    Eur J Med Chem; 2013 Jun; 64():99-110. PubMed ID: 23644193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
    Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
    Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and preliminary biological evaluation of 1,2,3-triazole-Jaspine B hybrids as potential cytotoxic agents.
    Xu JM; Zhang E; Shi XJ; Wang YC; Yu B; Jiao WW; Guo YZ; Liu HM
    Eur J Med Chem; 2014 Jun; 80():593-604. PubMed ID: 24835817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
    Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
    Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitumor activities of novel 1,4-disubstituted phthalazine derivatives.
    Zhang S; Zhao Y; Liu Y; Chen D; Lan W; Zhao Q; Dong C; Xia L; Gong P
    Eur J Med Chem; 2010 Aug; 45(8):3504-10. PubMed ID: 20537434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of novel 1,2,3-triazole-pyrimidine-urea hybrids as potential anticancer agents.
    Ma LY; Wang B; Pang LP; Zhang M; Wang SQ; Zheng YC; Shao KP; Xue DQ; Liu HM
    Bioorg Med Chem Lett; 2015 Mar; 25(5):1124-8. PubMed ID: 25655718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents.
    Shao KP; Zhang XY; Chen PJ; Xue DQ; He P; Ma LY; Zheng JX; Zhang QR; Liu HM
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3877-81. PubMed ID: 25001482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and in vitro evaluation of novel ursolic acid derivatives as potential anticancer agents.
    Hua SX; Huang RZ; Ye MY; Pan YM; Yao GY; Zhang Y; Wang HS
    Eur J Med Chem; 2015 May; 95():435-52. PubMed ID: 25841199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel triazolophthalazine-hydrazone hybrids as potential PCAF inhibitors: Design, synthesis, in vitro anticancer evaluation, apoptosis, and molecular docking studies.
    Abulkhair HS; Turky A; Ghiaty A; Ahmed HEA; Bayoumi AH
    Bioorg Chem; 2020 Jul; 100():103899. PubMed ID: 32454390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.
    Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R
    Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of novel 1,2,4-triazolo [3,4-b][1,3,4] thiadiazines bearing furan and thiophene nucleus.
    Zhang B; Li YH; Liu Y; Chen YR; Pan ES; You WW; Zhao PL
    Eur J Med Chem; 2015 Oct; 103():335-42. PubMed ID: 26363869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antimicrobial activities of novel 1,2,4-triazolo [3,4-a] phthalazine derivatives.
    Zhang QR; Xue DQ; He P; Shao KP; Chen PJ; Gu YF; Ren JL; Shan LH; Liu HM
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1236-8. PubMed ID: 24447849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
    Kassab AE; Hassan RA
    Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of novel 3-alkylsulfanyl-4-amino-1,2,4-triazole derivatives.
    Zhao PL; Chen P; Li Q; Hu MJ; Diao PC; Pan ES; You WW
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3679-83. PubMed ID: 27287368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of [1,2,3]triazolo[4,5-d]pyrimidine derivatives possessing a hydrazone moiety as antiproliferative agents.
    Li ZH; Yang DX; Geng PF; Zhang J; Wei HM; Hu B; Guo Q; Zhang XH; Guo WG; Zhao B; Yu B; Ma LY; Liu HM
    Eur J Med Chem; 2016 Nov; 124():967-980. PubMed ID: 27771599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From triazolophthalazines to triazoloquinazolines: A bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity.
    El-Shershaby MH; Ghiaty A; Bayoumi AH; Al-Karmalawy AA; Husseiny EM; El-Zoghbi MS; Abulkhair HS
    Bioorg Med Chem; 2021 Jul; 42():116266. PubMed ID: 34126285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.